Cargando…
Perspectives for TNF-α-targeting therapies
CHAPTER SUMMARY: Rheumatoid arthritis (RA) is the most common chronic autoimmunopathy, clinically leading to joint destruction as a consequence of the chronic inflammatory processes. The pathogenesis of this disabling disease is not well understood, but molecular events leading to tissue inflammatio...
Autores principales: | Lorenz, Hanns-Martin, Kalden, Joachim R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3240140/ https://www.ncbi.nlm.nih.gov/pubmed/12110119 http://dx.doi.org/10.1186/ar564 |
Ejemplares similares
-
Anti-TNF therapy: what have we learned in 12 years?
por: Kalden, Joachim R
Publicado: (2011) -
Targeting TNF-α for cancer therapy
por: Burton, Elizabeth R, et al.
Publicado: (2009) -
Defective Suppressor Function of Human CD4(+) CD25(+) Regulatory T Cells in Autoimmune Polyglandular Syndrome Type II
por: Kriegel, Martin A., et al.
Publicado: (2004) -
Advances in rheumatology: new targeted therapeutics
por: Tak, Paul P, et al.
Publicado: (2011) -
TNFα inhibitors as targets for protective therapies in MSA: a viewpoint
por: Ndayisaba, Alain, et al.
Publicado: (2019)